AU4168899A - Benzanilide derivatives and medicinal compositions - Google Patents

Benzanilide derivatives and medicinal compositions

Info

Publication number
AU4168899A
AU4168899A AU41688/99A AU4168899A AU4168899A AU 4168899 A AU4168899 A AU 4168899A AU 41688/99 A AU41688/99 A AU 41688/99A AU 4168899 A AU4168899 A AU 4168899A AU 4168899 A AU4168899 A AU 4168899A
Authority
AU
Australia
Prior art keywords
medicinal compositions
benzanilide derivatives
benzanilide
derivatives
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41688/99A
Other languages
English (en)
Inventor
Katsuhiro Kawano
Akira Naito
Kenji Naito
Yasuhiro Ohtake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakamoto Pharmaceutical Co Ltd
Original Assignee
Wakamoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharmaceutical Co Ltd filed Critical Wakamoto Pharmaceutical Co Ltd
Publication of AU4168899A publication Critical patent/AU4168899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AU41688/99A 1998-06-19 1999-06-18 Benzanilide derivatives and medicinal compositions Abandoned AU4168899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP18807198A JP2002179651A (ja) 1998-06-19 1998-06-19 ベンズアニリド誘導体及び医薬組成物
JP10/188071 1998-06-19
PCT/JP1999/003276 WO1999065874A1 (fr) 1998-06-19 1999-06-18 Derives de benzanilide et compositions medicinales

Publications (1)

Publication Number Publication Date
AU4168899A true AU4168899A (en) 2000-01-05

Family

ID=16217208

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41688/99A Abandoned AU4168899A (en) 1998-06-19 1999-06-18 Benzanilide derivatives and medicinal compositions

Country Status (3)

Country Link
JP (1) JP2002179651A (ja)
AU (1) AU4168899A (ja)
WO (1) WO1999065874A1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003045393A1 (en) * 2001-11-30 2003-06-05 F. Hoffmann-La Roche Ag Piperazine derivatives for use as ccr-3 receptor antagonists in the treatment of asthma
GB0215676D0 (en) 2002-07-05 2002-08-14 Novartis Ag Organic compounds
JP2007525460A (ja) * 2003-04-25 2007-09-06 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド ｃ−ｆｍｓキナーゼ阻害剤
JP4771468B2 (ja) * 2003-12-26 2011-09-14 正敏 萩原 Ｓｒ蛋白質のリン酸化制御方法、および、ｓｒ蛋白質の活性制御剤を有効成分とする抗ウイルス剤
US7625949B2 (en) 2004-04-23 2009-12-01 Roche Palo Alto Llc Methods for treating retroviral infections
US7166738B2 (en) 2004-04-23 2007-01-23 Roche Palo Alto Llc Non-nucleoside reverse transcriptase inhibitors
CA2563180C (en) * 2004-04-23 2013-08-06 F. Hoffmann-La Roche Ag Non-nucleoside reverse transcriptase inhibitors
US8350043B2 (en) 2005-06-07 2013-01-08 Pharmacopeia, Inc. Azinone and diazinone V3 inhibitors for depression and stress disorders
WO2007045573A1 (en) 2005-10-19 2007-04-26 F. Hoffmann-La Roche Ag Phenyl-acetamide nnrt inhibitors
CA2735158C (en) * 2008-08-29 2016-11-08 Treventis Corporation Compositions and methods of treating amyloid disease
KR20140083058A (ko) * 2011-11-08 2014-07-03 아레나 파마슈티칼스, 인크. G 단백질-커플링된 Mas 수용체의 조절제 및 그와 관련된 장애의 치료
WO2014182673A1 (en) * 2013-05-07 2014-11-13 Arena Pharmaceuticals, Inc. Modulators of the g protein-coupled mas receptor and the treatment of disorders related thereto
PE20181178A1 (es) * 2015-08-28 2018-07-20 Glenmark Pharmaceuticals Sa Compuestos carbocilicos novedosos como moduladores de ror gamma
TW201920081A (zh) 2017-07-11 2019-06-01 美商維泰克斯製藥公司 作為鈉通道調節劑的羧醯胺

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408185D0 (en) * 1994-04-25 1994-06-15 Fujisawa Pharmaceutical Co New benzamide derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
AUPO395396A0 (en) * 1996-12-02 1997-01-02 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives

Also Published As

Publication number Publication date
JP2002179651A (ja) 2002-06-26
WO1999065874A1 (fr) 1999-12-23

Similar Documents

Publication Publication Date Title
HUP0103406A3 (en) 1h-imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0102990A3 (en) Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof
IL138899A0 (en) Amidene derivatives and pharmaceutical compositions containing the same
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
AU2001290257A2 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2319100A (en) Amide derivatives and drug compositions
IL138573A0 (en) Amide derivatives and pharmaceutical compositions containing the same
IL131319A0 (en) 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same
IL143920A0 (en) 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
HUP0101381A3 (en) Benzofurylpyrone derivatives and pharmaceutical compositions containing them
AU5880498A (en) New benzolactam derivatives and medicinal compositions containing the same
HUP0103203A3 (en) Azaadamantane derivatives and pharmaceutical compositions thereof
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
IL147214A0 (en) 1-methylcarbapenem derivatives and pharmaceutical compositions containing the same
AU5565099A (en) Pharmaceutical compositions and methods for use
AU5161399A (en) N-benzocycloalkyl-amide derivatives and their use as medicaments
HUP0100680A3 (en) Indole derivatives and medicinal compositions containing the same
AU4168899A (en) Benzanilide derivatives and medicinal compositions
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
HUP0003398A3 (en) Novel triptolide derivatives and pharmaceutical compositions thereof
HUP0104852A3 (en) Oktahydro-pyrido-pyrazine derivatives and pharmaceutical compositions containing the same and their use
AU6213699A (en) Nutritional and pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase